Ultragenyx Pharmaceutical | RARE - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -11.37M 150.72M 2026-06
Ionis Pharmaceuticals USD -114M 21M 2026-06
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
Kyowa Hakko Kirin JPY 23.54B 9.62B 2026-06
MacroGenics USD -36.77M 21.84M 2026-03
Moderna USD -1.33B 535M 2026-03
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
PTC Therapeutics USD -2.46M 136.62M 2026-03
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Ultragenyx Pharmaceutical USD -91M 93M 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06